Prefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated daily over 4–6 weeks (20–30 sessions) is US Food and Drug Administration (FDA) approved for treating Major Depressive Dis- order in adults who have not responded to prior antidepressant medications. In 2011, leading TMS clinical providers and researchers created the Clinical TMS Society (cTMSs)
Tarique Perera a, Mark S. George b,c, Geoffrey Grammer d, Philip G. Janicak e, Alvaro Pascual-Leone f, Theodore S. Wirecki g
